These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

613 related articles for article (PubMed ID: 28822825)

  • 41. Vertebral bone resorption after transforaminal lumbar interbody fusion with bone morphogenetic protein (rhBMP-2).
    McClellan JW; Mulconrey DS; Forbes RJ; Fullmer N
    J Spinal Disord Tech; 2006 Oct; 19(7):483-6. PubMed ID: 17021411
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Retrograde ejaculation following single-level anterior lumbar surgery with or without recombinant human bone morphogenetic protein-2 in 5 randomized controlled trials: clinical article.
    Burkus JK; Dryer RF; Peloza JH
    J Neurosurg Spine; 2013 Feb; 18(2):112-21. PubMed ID: 23199378
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Complications with recombinant human bone morphogenetic protein-2 in posterolateral spine fusion associated with a dural tear.
    Glassman SD; Gum JL; Crawford CH; Shields CB; Carreon LY
    Spine J; 2011 Jun; 11(6):522-6. PubMed ID: 20598649
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Complications with the use of bone morphogenetic protein 2 (BMP-2) in spine surgery.
    Tannoury CA; An HS
    Spine J; 2014 Mar; 14(3):552-9. PubMed ID: 24412416
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pseudo-Pedicle Heterotopic Ossification From Use of Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) in Transforaminal Lumbar Interbody Fusion Cages.
    Rosen CD; Kiester PD; Lee TQ
    Am J Orthop (Belle Mead NJ); 2018 Jan; 47(1):. PubMed ID: 29447305
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Routine use of recombinant human bone morphogenetic protein-2 in posterior fusions of the pediatric spine and incidence of cancer.
    Sayama C; Willsey M; Chintagumpala M; Brayton A; Briceño V; Ryan SL; Luerssen TG; Hwang SW; Jea A
    J Neurosurg Pediatr; 2015 Jul; 16(1):4-13. PubMed ID: 25860984
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A prospective, randomized, controlled trial comparing radiographic and clinical outcomes between stand-alone lateral interbody lumbar fusion with either silicate calcium phosphate or rh-BMP2.
    Pimenta L; Marchi L; Oliveira L; Coutinho E; Amaral R
    J Neurol Surg A Cent Eur Neurosurg; 2013 Nov; 74(6):343-50. PubMed ID: 23444134
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Blood serum antibody analysis and long-term follow-up of patients treated with recombinant human bone morphogenetic protein-2 in the lumbar spine.
    Burkus JK; Gornet MF; Glassman SD; Slosar PJ; Rosner MK; Deckey JE; Nowak J; Hatcher BM
    Spine (Phila Pa 1976); 2011 Dec; 36(25):2158-67. PubMed ID: 21325990
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Perioperative complications with rhBMP-2 in transforaminal lumbar interbody fusion.
    Owens K; Glassman SD; Howard JM; Djurasovic M; Witten JL; Carreon LY
    Eur Spine J; 2011 Apr; 20(4):612-7. PubMed ID: 20582554
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vertebral osteolysis originating from subchondral cyst end plate defects in transforaminal lumbar interbody fusion using rhBMP-2. Report of two cases.
    Balseiro S; Nottmeier EW
    Spine J; 2010 Jul; 10(7):e6-e10. PubMed ID: 20488766
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Complications of anterior cervical discectomy and fusion using recombinant human bone morphogenetic protein-2.
    Vaidya R; Carp J; Sethi A; Bartol S; Craig J; Les CM
    Eur Spine J; 2007 Aug; 16(8):1257-65. PubMed ID: 17387522
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Promoting fusion in minimally invasive lumbar interbody stabilization with low-dose bone morphogenic protein-2--but what is the cost?
    Mannion RJ; Nowitzke AM; Wood MJ
    Spine J; 2011 Jun; 11(6):527-33. PubMed ID: 20739225
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adjuncts in posterior lumbar spine fusion: comparison of complications and efficacy.
    Hoffmann MF; Jones CB; Sietsema DL
    Arch Orthop Trauma Surg; 2012 Aug; 132(8):1105-10. PubMed ID: 22562366
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2: a prospective study of complications.
    Malham GM; Parker RM; Ellis NJ; Blecher CM; Chow FY; Claydon MH
    J Neurosurg Spine; 2014 Dec; 21(6):851-60. PubMed ID: 25279655
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fusion rate of Escherichia coli-derived recombinant human bone morphogenetic protein-2 compared with local bone autograft in posterior lumbar interbody fusion for degenerative lumbar disorders.
    Park S; Jeong YH; Ha BJ; Yoo BS; Kim SH; Lee CK; Yi S; Ha Y; Kim KN; Shin DA
    Spine J; 2023 Dec; 23(12):1877-1885. PubMed ID: 37516282
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neurologic impairment from ectopic bone in the lumbar canal: a potential complication of off-label PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2).
    Wong DA; Kumar A; Jatana S; Ghiselli G; Wong K
    Spine J; 2008; 8(6):1011-8. PubMed ID: 18037352
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Retrograde ejaculation after anterior lumbar interbody fusion using rhBMP-2: a cohort controlled study.
    Carragee EJ; Mitsunaga KA; Hurwitz EL; Scuderi GJ
    Spine J; 2011 Jun; 11(6):511-6. PubMed ID: 21612985
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis.
    Crawford CH; Carreon LY; McGinnis MD; Campbell MJ; Glassman SD
    Spine (Phila Pa 1976); 2009 Jun; 34(13):1390-4. PubMed ID: 19440166
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Complications associated with the use of the recombinant human bone morphogenetic proteins for posterior interbody fusions of the lumbar spine.
    Chrastil J; Low JB; Whang PG; Patel AA
    Spine (Phila Pa 1976); 2013 Jul; 38(16):E1020-7. PubMed ID: 23629484
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Longer follow-up continues to reveal no increased risk of cancer with the use of recombinant human bone morphogenetic protein in spine fusion.
    Dettori JR; Chapman JR; DeVine JG; McGuire RA; Junge MR; Norvell DC
    Spine J; 2019 Oct; 19(10):1640-1647. PubMed ID: 31108234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.